Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
236.7 USD | +2.11% | +7.32% | +15.24% |
Jun. 03 | Cencora Insider Sold Shares Worth $419,506, According to a Recent SEC Filing | MT |
May. 30 | Cencora, Inc. Revises Earnings Guidance for the Fiscal Year 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.16 for the 2024 fiscal year.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.24% | 45.64B | B- | ||
-5.27% | 180B | C+ | ||
-0.05% | 108B | C | ||
-1.50% | 68.29B | A | ||
-7.12% | 46.96B | B- | ||
+7.80% | 42.41B | B+ | ||
+18.56% | 31.01B | B | ||
+16.68% | 25.51B | A- | ||
-6.84% | 23.17B | B | ||
-10.49% | 23.14B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- COR Stock
- Ratings Cencora, Inc.